|
Pharmaceutical Name (substance): Infliximab
Common Brand, Trade, Commercial Denominations: Remicade, cA2.
Manufacturers: Schering - Plough, Centocor, Johnson & Johnson.
IUPAC name: therapeutic monoclonal antibody
Molecular formula: C6428H9912N1694O1987S46
Molecular mass: 144190.3 g/mol
Bioavailability: 100% (IV)
Half life: 9.5 days
IUPAC-Name:CAS number: 170277-31-3
Routes: IV - intravenous
Drug category: inflammatory bowel disease therapy agent, antirheumatic agent
Drug class: immunomodulatory agents, immunosuppressive agents
|
